Integral Diagnostics (ASX:IDX) Dividend Payout Ratio: 1.67 (As of Dec. 2025) — 132% Above Median


ASX:IDX Integral Diagnostics Ltd ASX:IDX
73 GF Score
Price A$2.00
GF Value A$2.78
Valuation Modestly Undervalued
! 9 Warning Signs
View Full Analysis

What is Integral Diagnostics Dividend Payout Ratio?

Integral Diagnostics ASX:IDX -0.50% 73 Dividend Payout Ratio is 1.67 as of Dec. 2025, which is 132% above its 10-year median of 0.72. GuruFocus rates ASX:IDX with a GF Score™ of 73/100 and a GF Value™ of A$2.78 (Modestly Undervalued). The stock has 9 warning signs investors should review. Among 55 Medical Diagnostics & Research companies, Integral Diagnostics ranks worse than 87.27% on this metric.

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Integral Diagnostics's Dividend Payout Ratio for the months ended in Dec. 2025 was 1.67.

Warning Sign:

If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Integral Diagnostics Ltd is 1.55, which seems too high.

The historical rank and industry rank for Integral Diagnostics's Dividend Payout Ratio or its related term are showing as below:

ASX:IDX' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.57   Med: 0.72   Max: 31.33
Current: 1.55

During the past 10 years, the highest Dividend Payout Ratio of Integral Diagnostics was 31.33. The lowest was 0.57. And the median was 0.72.

ASX:IDX's Dividend Payout Ratio is ranked worse than
87.27% of 55 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.49 vs ASX:IDX: 1.55

As of today (2026-06-28), the Dividend Yield % of Integral Diagnostics is 3.65%.

During the past 10 years, the highest Trailing Annual Dividend Yield of Integral Diagnostics was 4.74%. The lowest was 1.68%. And the median was 2.56%.

Integral Diagnostics's Dividends per Share for the months ended in Dec. 2025 was A$0.04.

During the past 12 months, Integral Diagnostics's average Dividends Per Share Growth Rate was 12.10% per year. During the past 3 years, the average Dividends Per Share Growth Rate was -19.00% per year. During the past 5 years, the average Dividends Per Share Growth Rate was -13.20% per year.

During the past 10 years, the highest 3-Year average Dividends Per Share Growth Rate of Integral Diagnostics was 15.20% per year. The lowest was -19.10% per year. And the median was -3.50% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Integral Diagnostics (ASX:IDX) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Integral Diagnostics Dividend Payout Ratio Related Terms

Integral Diagnostics Dividend Payout Ratio Historical Data

* Premium members only.

The historical data trend for Integral Diagnostics's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Integral Diagnostics Dividend Payout Ratio Chart

Integral Diagnostics Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 31.33 1.07 0.72 0.78 0.57

Integral Diagnostics Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.69 0.00 1.39 1.67

ASX:IDX vs TMO, DHR, IDXX: Dividend Payout Ratio Comparison

For the Diagnostics & Research subindustry, Integral Diagnostics's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Integral Diagnostics Dividend Payout Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Integral Diagnostics's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Integral Diagnostics's Dividend Payout Ratio falls into.


ASX:IDX
73GF Score
Integral Diagnostics Ltd ASX:IDX
Dividend Payout Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Integral Diagnostics Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

Integral Diagnostics's Dividend Payout Ratio for the fiscal year that ended in Jun. 2025 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Jun. 2025 )/ EPS without NRI (A: Jun. 2025 )
=0.058/ 0.102
=0.57

Integral Diagnostics's Dividend Payout Ratio for the quarter that ended in Dec. 2025 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Dec. 2025 )/ EPS without NRI (Q: Dec. 2025 )
=0.04/ 0.024
=1.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Dividend Payout Ratio →
What does a Dividend Payout Ratio of 1.67 mean?
Integral Diagnostics (ASX:IDX) has a Dividend Payout Ratio of 1.67 as of Dec. 2025. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Integral Diagnostics and its competitors. This is 132% above median its historical median of 0.72. Over the past decade, Integral Diagnostics' Dividend Payout Ratio has ranged from 0.57 to 31.33. According to the industry distribution chart, Integral Diagnostics ranks #48 out of 55 companies in the Medical Diagnostics & Research industry, placing it in the top 87.3%.
Is Integral Diagnostics' Dividend Payout Ratio too high?
Integral Diagnostics' current Dividend Payout Ratio of 1.67 is 132% above median its 10-year median of 0.72. Over the past 10 years, this metric has ranged from a low of 0.57 to a high of 31.33. The Medical Diagnostics & Research industry median Dividend Payout Ratio is 0.49. Integral Diagnostics' value of 1.67 is 240.8% above this industry median. Based on the distribution chart, Integral Diagnostics ranks #48 out of 55 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Integral Diagnostics has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Integral Diagnostics' Dividend Payout Ratio compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Integral Diagnostics ranks #48 out of 55 companies for Dividend Payout Ratio. This places Integral Diagnostics in the lower half of its industry. The industry median Dividend Payout Ratio is 0.49. Integral Diagnostics' value of 1.67 is 240.8% above this benchmark. Historically, Integral Diagnostics' own Dividend Payout Ratio has ranged from 0.57 to 31.33 over the past decade. While the company's 10-year median is 0.72 vs. the industry median of 0.49, Integral Diagnostics has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Medical Diagnostics & Research company?
The median Dividend Payout Ratio among Medical Diagnostics & Research companies is 0.49, based on 55 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Integral Diagnostics's current Dividend Payout Ratio of 1.67 is 240.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Integral Diagnostics and its competitors. For the Medical Diagnostics & Research industry, the median Dividend Payout Ratio is 0.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Integral Diagnostics's current Dividend Payout Ratio is 1.67, which is 132% above median its own 10-year median of 0.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Integral Diagnostics stock overvalued right now?
Based on GuruFocus' analysis, Integral Diagnostics (ASX:IDX) is currently considered Modestly Undervalued. The stock's GF Value™ is A$2.78, compared to a current price of A$2.00 — trading 28.1% below its estimated fair value. The current Dividend Payout Ratio is 1.67, which is 132% above median its 10-year median of 0.72 and 240.8% above the Medical Diagnostics & Research industry median of 0.49. Integral Diagnostics' overall GF Score™ is 73/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Integral Diagnostics (ASX:IDX), the current Dividend Payout Ratio is 1.67 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Integral Diagnostics (ASX:IDX) Overvalued in 2026?

Based on GuruFocus' analysis, Integral Diagnostics stock appears to be undervalued. The current stock price of A$2.00 is trading 28.1% below its estimated GF Value™ of A$2.78. GuruFocus considers Integral Diagnostics to be Modestly Undervalued.

Key valuation signals for ASX:IDX:

  • Dividend Payout Ratio: 1.67 (132% above median its 10-year median of 0.72)
  • GF Value™: A$2.78 vs. price of A$2.00 (28.1% below fair value)
  • GF Score™: 73/100 with 9 warning signs
  • Industry Position: 240.8% above the Medical Diagnostics & Research median (#48 of 55)

No single metric tells the full story. See the ASX:IDX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Integral Diagnostics Business Description

Address 288 Victoria Parade, Level 2, Melbourne, VIC, AUS, 3002
Integral Diagnostics is a major Australian diagnostic imaging provider. In Australia, imaging revenues are almost entirely earned via the public health Medicare system. Integral typically earns approximately 90% of group revenue from diagnostic imaging in Australia and the remainder from diagnostic imaging in Auckland, New Zealand. In Australia, Integral services regional areas in Queensland, Victoria, New South Wales, and Western Australia.
73GF Score

Get the complete analysis for ASX:IDX

Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$2.00
Price
A$2.78
GF Value